Scotiabank analyst Tristan Richardson initiates coverage on NEXTracker (NASDAQ:NXT) with a Sector Outperform rating.
Needham Maintains Buy on Avadel Pharmaceuticals, Maintains $11 Price Target
Needham analyst Ami Fadia maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $11 price target.